Characterization of the behavior of alginate-based microcapsules in vitro and in vivo

International Journal of Clinical Pharmacology and Therapeutics

Volumn 47, Issue 9, 2009, Pages 556-563

  Anschütz, Maria ^a   Garbacz, G ^b   Kosch, O ^a   Donath, F ^a   Wiedmann, J ^c   Hoeckh, W ^c   Trahms, L ^d   Schug, B ^a   Weitschies, W ^b   Blume, H ^a  

^a SocraTec R and D   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c Cavis Microcaps GmbH   (Germany)

^d PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

Author keywords

Alginate based microcapsules; Functional food products; Gastrointestinal imaging; Gastrointestinal transit; Magnetic marker monitoring

Indexed keywords

ALGINIC ACID; ALPHA TOCOPHEROL; CASEIN; IRON OXIDE; STARCH; SUNFLOWER OIL; EXCIPIENT; MAGNETITE;

ADULT; ARTICLE; COLON; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG FORMULATION; DRUG METABOLISM; DRUG SAFETY; DRUG STABILITY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROCAPSULE; NORMAL HUMAN; PH; SMALL INTESTINE; STOMACH EMPTYING; STOMACH JUICE; SWELLING; TABLET DISINTEGRATION; CHEMISTRY; GASTROINTESTINAL TRANSIT; PHYSIOLOGY; SEXUAL DEVELOPMENT; SOLUBILITY; STOMACH;

ADULT; ALGINATES; CAPSULES; CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; FEMALE; FERROSOFERRIC OXIDE; GASTRIC EMPTYING; GASTROINTESTINAL TRANSIT; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; SEX CHARACTERISTICS; SOLUBILITY; STARCH; STOMACH; YOUNG ADULT;

EID: 70349905248     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP47556     Document Type: Article

References (11)

1. Cook IJ, Furukawa Y, Panagopoulos V, Collins PJ, Dent J. Relationships between spatial patterns of colonic pressure and individual movements of content. Am J Physiol Gastrointest Liver Physiol. 2000; 278: G329-341.
2. Davis SS, Hardy JG, Fara JW. Transit of pharmaceutical dosage forms through the small intestine. Gut. 1986; 27: 886-892.
3. Dinning PG, Bampton PA, Kennedy ML, Kajimoto T, Lubowski DZ, de Carle DJ, Cook IJ. Basal pressure patterns and reflexive motor responses in the human ileocolonic junction. Am J Physiol. 1999; 276: G331-G340.
4. Galia E, Nicolaides E, Hörter D, Löbenberg R, Reppas C, Dressman JB. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res. 1998; 15: 698-705.
5. Indireshkumar K, Brasseur JG, Faas H, Hebbard GS, Kunz P, Dent J, Feinle C, Li M, Boesiger P, Fried M, Schwizer W. Relative contributions of "pressure pump" and "peristaltic pump" to gastric emptying. Am J Physiol Gastrointest Liver Physiol. 2000; 278: G604-G616.
6. Le Coz CJ, Leclere JM, Arnoult E, Raison-Peyron N, Pons-Guiraud A, Vigan M. Members of Revidal-Gerda. Allergic contact dermatitis from shellac in mascara. Contact Dermatitis. 2002; 46: 149-152.
7. Pearnchob N, Siepmann J, Bodmeier R. Pharmaceutical applications of shellac: moisture-protective and taste-masking coatings and extended-release matrix tablets. Drug Dev Ind Pharm. 2003; 29: 925-938.
8. Pearnchob N, Dashevsky A, Bodmeier R. Improvement in the disintegration of shellac-coated soft gelatin capsules in simulated intestinal fluid. J Contr Release. 2004; 10: 313-321.
9. Weitschies W, Kosch O, Monnikes H, Trahms L. Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv Drug Deliv Rev. 2005a; 57: 1210-1222.
10. Weitschies W, Wedemeyer RS, Kosch O, Fach K, Nagel S, Söderlind E, Trahms L, Abrahamsson B, Mönnikes H. Impact of the intragastric location of extended release tablets on food interactions. J Control Release. 2005b; 28: 375-385.
11. Wilding I. Site-specific drug delivery in the gastrointestinal tract. Crit Rev Ther Drug Carrier Syst. 2000; 17: 557-620.